A 2024 study by Rahaman et al. (Journal of Chromatography B, PMID 38382158) looked at how TB-500 breaks down in the body. What they found is not what forums and social media will have you believe.
Core finding
TB-500 converts into a smaller metabolite called Ac-LKKTE. The wound-healing benefits people credit to TB-500 might actually be coming from this metabolite, not TB-500 itself.
If that turns out to be true, TB-500 might just be acting as a delivery vehicle — something that converts into the molecule actually doing the work.
This does not mean TB-500 is useless
It would still explain the effects people see. It just adds another wrinkle to an already complicated picture of how well Tβ4 research actually applies to TB-500 use.
Status of this finding
This finding has shown up in later papers, but you won’t find it mentioned in most consumer content about TB-500. It also hasn’t been independently confirmed by other researchers as of mid-2026.
Conclusion
The Rahaman 2024 finding suggests the active molecule may be neither TB-500 nor full-length Tβ4, but a third substance altogether. This possibility deserves ongoing attention.